SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹144 Cr | ₹77 Cr | ₹61 Cr | ₹52 Cr | ₹41 Cr |
What is the latest Total Liabilities ratio of SHREE GANESH REMEDIES ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹144 Cr |
Mar2022 | ₹77 Cr |
Mar2021 | ₹61 Cr |
Mar2020 | ₹52 Cr |
Mar2019 | ₹41 Cr |
How is Total Liabilities of SHREE GANESH REMEDIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹144 Cr | 86.65 | |
Mar2022 | ₹77 Cr | 27.09 | |
Mar2021 | ₹61 Cr | 15.95 | |
Mar2020 | ₹52 Cr | 26.41 | |
Mar2019 | ₹41 Cr | - |
Compare Total Liabilities of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹774.3 Cr | 2.8% | -2.5% | 107.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹354,706.0 Cr | -1.1% | -2.9% | 55.1% | Stock Analytics | |
CIPLA | ₹120,556.0 Cr | 0.3% | 6.1% | 56.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹118,095.0 Cr | 8.2% | 11.5% | 27.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,162.0 Cr | -3.7% | 8.5% | 107.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,086.0 Cr | 1.8% | -4.7% | 32.3% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 2.8% |
-2.5% |
107.7% |
SENSEX | 0.4% |
1.1% |
20.6% |
You may also like the below Video Courses